TODAY’S NEWS Celgene to buy Gloucester Pharmaceuticals, another company with a focus on developing drugs for blood cancer. I really like Celgene's laser-like focus in its product portfolio - very …
Impactiviti Daily 110209
TODAY’S NEWS Takeda buys into Amylin's weight-loss drug portfolio - Takeda will pay $75 million upfront for medicines including Amylin’s pramlintide/metreleptin and davalintide, in the second phase …
Impactiviti Daily 081809
NEWS Will Provenge take a big bite out of Taxotere? Provenge is an immunotherapy, meaning the vaccine stimulates the immune system to attack a specific target, in this case prostate cancer cells. It …
Today’s Pharma News 081709
Novartis gets FDA approval for MS drug Extavia. Extavia is essentially re-branded Betaseron, and marks the entry of a new (and large player) into the MS market. It's Novartis' MS pipeline that's …
Today’s Top Pharma News 081009
After a couple weeks of vacation and stepping-back time, I'm once again pulling together the daily pharma news. Well, today, anyway - might not be able to do so for the rest of the week due to a …
Today’s Top Pharma News 071609
FDA to Zeltia: NO - An FDA advisory committee has handed Spain's Zeltia a crushing blow, deciding against a combination therapy that includes its lead cancer drug Yondelis (trabectedin) by a vote of …